A novel amyloid designable scaffold and potential inhibitor inspired by GAIIG of amyloid beta and the HIV‐1 V3 loop

The GAIIG sequence, common to the amyloid beta peptide (residues 29–33) and to the HIV‐1 gp120 (residues 24–28 in a typical V3 loop), self‐assembles into amyloid fibrils, as suggested by theory and the experiments presented here. The longer YATGAIIGNII sequence from the V3 loop also self‐assembles i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:FEBS letters 2018-06, Vol.592 (11), p.1777-1788
Hauptverfasser: Kokotidou, Chrysoula, Jonnalagadda, Sai Vamshi R., Orr, Asuka A., Seoane‐Blanco, Mateo, Apostolidou, Chrysanthi Pinelopi, Raaij, Mark J., Kotzabasaki, Marianna, Chatzoudis, Apostolos, Jakubowski, Joseph M., Mossou, Estelle, Forsyth, V. Trevor, Mitchell, Edward P., Bowler, Matthew W., Llamas‐Saiz, Antonio L., Tamamis, Phanourios, Mitraki, Anna
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1788
container_issue 11
container_start_page 1777
container_title FEBS letters
container_volume 592
creator Kokotidou, Chrysoula
Jonnalagadda, Sai Vamshi R.
Orr, Asuka A.
Seoane‐Blanco, Mateo
Apostolidou, Chrysanthi Pinelopi
Raaij, Mark J.
Kotzabasaki, Marianna
Chatzoudis, Apostolos
Jakubowski, Joseph M.
Mossou, Estelle
Forsyth, V. Trevor
Mitchell, Edward P.
Bowler, Matthew W.
Llamas‐Saiz, Antonio L.
Tamamis, Phanourios
Mitraki, Anna
description The GAIIG sequence, common to the amyloid beta peptide (residues 29–33) and to the HIV‐1 gp120 (residues 24–28 in a typical V3 loop), self‐assembles into amyloid fibrils, as suggested by theory and the experiments presented here. The longer YATGAIIGNII sequence from the V3 loop also self‐assembles into amyloid fibrils, of which the first three and the last two residues are outside the amyloid GAIIG core. We postulate that this sequence, with suitably selected modifications at the flexible positions, can serve as a designable scaffold for novel amyloid‐based materials. Moreover, we report the single crystal X‐ray structure of the beta‐breaker peptide GAIPIG at 1.05 Å resolution. The structural information provided in this study could serve as the basis for structure‐based design of potential inhibitors of amyloid formation.
doi_str_mv 10.1002/1873-3468.13096
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2041631065</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2041631065</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3856-e6106024ba05c38c732ccbf92bc33cd616d265614ae327a1d07ed60ab12162643</originalsourceid><addsrcrecordid>eNqFkLtOwzAUQC0EouUxsyGPLCl-JE4zlqovCYkFWC0_bqiRG4c4BXXjE_hGvoSUlq5Mtq_OPZYOQleUDCgh7JYOc57wVAwHlJNCHKH-YXKM-oTQNMnygvfQWYyvpHsPaXGKeqzIcyYI76P1CFfhHTxWq40PzmIL0b1USnvA0aiyDN5iVVlchxaq1imPXbV02rWh6W6xdg1YrDd4NlosZjiUB5GGVv1utkvA88Xz9-cXxc8c-xDqC3RSKh_hcn-eo6fp5HE8T-4fZovx6D4xfJiJBAQlgrBUK5J1E5NzZowuC6YN58YKKiwTmaCpAs5yRS3JwQqiNGVUMJHyc3Sz89ZNeFtDbOXKRQPeqwrCOkpGUip490nWobc71DQhxgZKWTdupZqNpERuW8ttWbktK39bdxvXe_lar8Ae-L-4HSB2wIfzsPnPJ6eTO7Yz_wAgOYg-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2041631065</pqid></control><display><type>article</type><title>A novel amyloid designable scaffold and potential inhibitor inspired by GAIIG of amyloid beta and the HIV‐1 V3 loop</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><source>Wiley Online Library (Open Access Collection)</source><source>Alma/SFX Local Collection</source><creator>Kokotidou, Chrysoula ; Jonnalagadda, Sai Vamshi R. ; Orr, Asuka A. ; Seoane‐Blanco, Mateo ; Apostolidou, Chrysanthi Pinelopi ; Raaij, Mark J. ; Kotzabasaki, Marianna ; Chatzoudis, Apostolos ; Jakubowski, Joseph M. ; Mossou, Estelle ; Forsyth, V. Trevor ; Mitchell, Edward P. ; Bowler, Matthew W. ; Llamas‐Saiz, Antonio L. ; Tamamis, Phanourios ; Mitraki, Anna</creator><creatorcontrib>Kokotidou, Chrysoula ; Jonnalagadda, Sai Vamshi R. ; Orr, Asuka A. ; Seoane‐Blanco, Mateo ; Apostolidou, Chrysanthi Pinelopi ; Raaij, Mark J. ; Kotzabasaki, Marianna ; Chatzoudis, Apostolos ; Jakubowski, Joseph M. ; Mossou, Estelle ; Forsyth, V. Trevor ; Mitchell, Edward P. ; Bowler, Matthew W. ; Llamas‐Saiz, Antonio L. ; Tamamis, Phanourios ; Mitraki, Anna</creatorcontrib><description>The GAIIG sequence, common to the amyloid beta peptide (residues 29–33) and to the HIV‐1 gp120 (residues 24–28 in a typical V3 loop), self‐assembles into amyloid fibrils, as suggested by theory and the experiments presented here. The longer YATGAIIGNII sequence from the V3 loop also self‐assembles into amyloid fibrils, of which the first three and the last two residues are outside the amyloid GAIIG core. We postulate that this sequence, with suitably selected modifications at the flexible positions, can serve as a designable scaffold for novel amyloid‐based materials. Moreover, we report the single crystal X‐ray structure of the beta‐breaker peptide GAIPIG at 1.05 Å resolution. The structural information provided in this study could serve as the basis for structure‐based design of potential inhibitors of amyloid formation.</description><identifier>ISSN: 0014-5793</identifier><identifier>EISSN: 1873-3468</identifier><identifier>DOI: 10.1002/1873-3468.13096</identifier><identifier>PMID: 29772603</identifier><language>eng</language><publisher>England</publisher><subject>amyloid ; Amyloid beta-Peptides - chemistry ; beta‐breaker ; Crystallography, X-Ray ; HIV Envelope Protein gp120 - chemistry ; HIV-1 - chemistry ; Humans ; peptide self‐assembly ; Protein Structure, Secondary</subject><ispartof>FEBS letters, 2018-06, Vol.592 (11), p.1777-1788</ispartof><rights>2018 Federation of European Biochemical Societies</rights><rights>2018 Federation of European Biochemical Societies.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3856-e6106024ba05c38c732ccbf92bc33cd616d265614ae327a1d07ed60ab12162643</citedby><cites>FETCH-LOGICAL-c3856-e6106024ba05c38c732ccbf92bc33cd616d265614ae327a1d07ed60ab12162643</cites><orcidid>0000-0001-7686-2238 ; 0000-0001-5072-1939 ; 0000-0001-9134-0366 ; 0000-0003-0380-3477 ; 0000-0003-4704-3131 ; 0000-0002-4781-1375 ; 0000-0002-1899-4942 ; 0000-0003-4375-2272 ; 0000-0002-3342-2651 ; 0000-0003-4628-526X ; 0000-0002-8203-3791 ; 0000-0002-0496-9025 ; 0000-0001-9809-9536 ; 0000-0003-4825-9022 ; 0000-0001-7327-238X ; 0000-0003-0465-3351</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F1873-3468.13096$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F1873-3468.13096$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,1434,27929,27930,45579,45580,46414,46838</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29772603$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kokotidou, Chrysoula</creatorcontrib><creatorcontrib>Jonnalagadda, Sai Vamshi R.</creatorcontrib><creatorcontrib>Orr, Asuka A.</creatorcontrib><creatorcontrib>Seoane‐Blanco, Mateo</creatorcontrib><creatorcontrib>Apostolidou, Chrysanthi Pinelopi</creatorcontrib><creatorcontrib>Raaij, Mark J.</creatorcontrib><creatorcontrib>Kotzabasaki, Marianna</creatorcontrib><creatorcontrib>Chatzoudis, Apostolos</creatorcontrib><creatorcontrib>Jakubowski, Joseph M.</creatorcontrib><creatorcontrib>Mossou, Estelle</creatorcontrib><creatorcontrib>Forsyth, V. Trevor</creatorcontrib><creatorcontrib>Mitchell, Edward P.</creatorcontrib><creatorcontrib>Bowler, Matthew W.</creatorcontrib><creatorcontrib>Llamas‐Saiz, Antonio L.</creatorcontrib><creatorcontrib>Tamamis, Phanourios</creatorcontrib><creatorcontrib>Mitraki, Anna</creatorcontrib><title>A novel amyloid designable scaffold and potential inhibitor inspired by GAIIG of amyloid beta and the HIV‐1 V3 loop</title><title>FEBS letters</title><addtitle>FEBS Lett</addtitle><description>The GAIIG sequence, common to the amyloid beta peptide (residues 29–33) and to the HIV‐1 gp120 (residues 24–28 in a typical V3 loop), self‐assembles into amyloid fibrils, as suggested by theory and the experiments presented here. The longer YATGAIIGNII sequence from the V3 loop also self‐assembles into amyloid fibrils, of which the first three and the last two residues are outside the amyloid GAIIG core. We postulate that this sequence, with suitably selected modifications at the flexible positions, can serve as a designable scaffold for novel amyloid‐based materials. Moreover, we report the single crystal X‐ray structure of the beta‐breaker peptide GAIPIG at 1.05 Å resolution. The structural information provided in this study could serve as the basis for structure‐based design of potential inhibitors of amyloid formation.</description><subject>amyloid</subject><subject>Amyloid beta-Peptides - chemistry</subject><subject>beta‐breaker</subject><subject>Crystallography, X-Ray</subject><subject>HIV Envelope Protein gp120 - chemistry</subject><subject>HIV-1 - chemistry</subject><subject>Humans</subject><subject>peptide self‐assembly</subject><subject>Protein Structure, Secondary</subject><issn>0014-5793</issn><issn>1873-3468</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkLtOwzAUQC0EouUxsyGPLCl-JE4zlqovCYkFWC0_bqiRG4c4BXXjE_hGvoSUlq5Mtq_OPZYOQleUDCgh7JYOc57wVAwHlJNCHKH-YXKM-oTQNMnygvfQWYyvpHsPaXGKeqzIcyYI76P1CFfhHTxWq40PzmIL0b1USnvA0aiyDN5iVVlchxaq1imPXbV02rWh6W6xdg1YrDd4NlosZjiUB5GGVv1utkvA88Xz9-cXxc8c-xDqC3RSKh_hcn-eo6fp5HE8T-4fZovx6D4xfJiJBAQlgrBUK5J1E5NzZowuC6YN58YKKiwTmaCpAs5yRS3JwQqiNGVUMJHyc3Sz89ZNeFtDbOXKRQPeqwrCOkpGUip490nWobc71DQhxgZKWTdupZqNpERuW8ttWbktK39bdxvXe_lar8Ae-L-4HSB2wIfzsPnPJ6eTO7Yz_wAgOYg-</recordid><startdate>201806</startdate><enddate>201806</enddate><creator>Kokotidou, Chrysoula</creator><creator>Jonnalagadda, Sai Vamshi R.</creator><creator>Orr, Asuka A.</creator><creator>Seoane‐Blanco, Mateo</creator><creator>Apostolidou, Chrysanthi Pinelopi</creator><creator>Raaij, Mark J.</creator><creator>Kotzabasaki, Marianna</creator><creator>Chatzoudis, Apostolos</creator><creator>Jakubowski, Joseph M.</creator><creator>Mossou, Estelle</creator><creator>Forsyth, V. Trevor</creator><creator>Mitchell, Edward P.</creator><creator>Bowler, Matthew W.</creator><creator>Llamas‐Saiz, Antonio L.</creator><creator>Tamamis, Phanourios</creator><creator>Mitraki, Anna</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7686-2238</orcidid><orcidid>https://orcid.org/0000-0001-5072-1939</orcidid><orcidid>https://orcid.org/0000-0001-9134-0366</orcidid><orcidid>https://orcid.org/0000-0003-0380-3477</orcidid><orcidid>https://orcid.org/0000-0003-4704-3131</orcidid><orcidid>https://orcid.org/0000-0002-4781-1375</orcidid><orcidid>https://orcid.org/0000-0002-1899-4942</orcidid><orcidid>https://orcid.org/0000-0003-4375-2272</orcidid><orcidid>https://orcid.org/0000-0002-3342-2651</orcidid><orcidid>https://orcid.org/0000-0003-4628-526X</orcidid><orcidid>https://orcid.org/0000-0002-8203-3791</orcidid><orcidid>https://orcid.org/0000-0002-0496-9025</orcidid><orcidid>https://orcid.org/0000-0001-9809-9536</orcidid><orcidid>https://orcid.org/0000-0003-4825-9022</orcidid><orcidid>https://orcid.org/0000-0001-7327-238X</orcidid><orcidid>https://orcid.org/0000-0003-0465-3351</orcidid></search><sort><creationdate>201806</creationdate><title>A novel amyloid designable scaffold and potential inhibitor inspired by GAIIG of amyloid beta and the HIV‐1 V3 loop</title><author>Kokotidou, Chrysoula ; Jonnalagadda, Sai Vamshi R. ; Orr, Asuka A. ; Seoane‐Blanco, Mateo ; Apostolidou, Chrysanthi Pinelopi ; Raaij, Mark J. ; Kotzabasaki, Marianna ; Chatzoudis, Apostolos ; Jakubowski, Joseph M. ; Mossou, Estelle ; Forsyth, V. Trevor ; Mitchell, Edward P. ; Bowler, Matthew W. ; Llamas‐Saiz, Antonio L. ; Tamamis, Phanourios ; Mitraki, Anna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3856-e6106024ba05c38c732ccbf92bc33cd616d265614ae327a1d07ed60ab12162643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>amyloid</topic><topic>Amyloid beta-Peptides - chemistry</topic><topic>beta‐breaker</topic><topic>Crystallography, X-Ray</topic><topic>HIV Envelope Protein gp120 - chemistry</topic><topic>HIV-1 - chemistry</topic><topic>Humans</topic><topic>peptide self‐assembly</topic><topic>Protein Structure, Secondary</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kokotidou, Chrysoula</creatorcontrib><creatorcontrib>Jonnalagadda, Sai Vamshi R.</creatorcontrib><creatorcontrib>Orr, Asuka A.</creatorcontrib><creatorcontrib>Seoane‐Blanco, Mateo</creatorcontrib><creatorcontrib>Apostolidou, Chrysanthi Pinelopi</creatorcontrib><creatorcontrib>Raaij, Mark J.</creatorcontrib><creatorcontrib>Kotzabasaki, Marianna</creatorcontrib><creatorcontrib>Chatzoudis, Apostolos</creatorcontrib><creatorcontrib>Jakubowski, Joseph M.</creatorcontrib><creatorcontrib>Mossou, Estelle</creatorcontrib><creatorcontrib>Forsyth, V. Trevor</creatorcontrib><creatorcontrib>Mitchell, Edward P.</creatorcontrib><creatorcontrib>Bowler, Matthew W.</creatorcontrib><creatorcontrib>Llamas‐Saiz, Antonio L.</creatorcontrib><creatorcontrib>Tamamis, Phanourios</creatorcontrib><creatorcontrib>Mitraki, Anna</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>FEBS letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kokotidou, Chrysoula</au><au>Jonnalagadda, Sai Vamshi R.</au><au>Orr, Asuka A.</au><au>Seoane‐Blanco, Mateo</au><au>Apostolidou, Chrysanthi Pinelopi</au><au>Raaij, Mark J.</au><au>Kotzabasaki, Marianna</au><au>Chatzoudis, Apostolos</au><au>Jakubowski, Joseph M.</au><au>Mossou, Estelle</au><au>Forsyth, V. Trevor</au><au>Mitchell, Edward P.</au><au>Bowler, Matthew W.</au><au>Llamas‐Saiz, Antonio L.</au><au>Tamamis, Phanourios</au><au>Mitraki, Anna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A novel amyloid designable scaffold and potential inhibitor inspired by GAIIG of amyloid beta and the HIV‐1 V3 loop</atitle><jtitle>FEBS letters</jtitle><addtitle>FEBS Lett</addtitle><date>2018-06</date><risdate>2018</risdate><volume>592</volume><issue>11</issue><spage>1777</spage><epage>1788</epage><pages>1777-1788</pages><issn>0014-5793</issn><eissn>1873-3468</eissn><abstract>The GAIIG sequence, common to the amyloid beta peptide (residues 29–33) and to the HIV‐1 gp120 (residues 24–28 in a typical V3 loop), self‐assembles into amyloid fibrils, as suggested by theory and the experiments presented here. The longer YATGAIIGNII sequence from the V3 loop also self‐assembles into amyloid fibrils, of which the first three and the last two residues are outside the amyloid GAIIG core. We postulate that this sequence, with suitably selected modifications at the flexible positions, can serve as a designable scaffold for novel amyloid‐based materials. Moreover, we report the single crystal X‐ray structure of the beta‐breaker peptide GAIPIG at 1.05 Å resolution. The structural information provided in this study could serve as the basis for structure‐based design of potential inhibitors of amyloid formation.</abstract><cop>England</cop><pmid>29772603</pmid><doi>10.1002/1873-3468.13096</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-7686-2238</orcidid><orcidid>https://orcid.org/0000-0001-5072-1939</orcidid><orcidid>https://orcid.org/0000-0001-9134-0366</orcidid><orcidid>https://orcid.org/0000-0003-0380-3477</orcidid><orcidid>https://orcid.org/0000-0003-4704-3131</orcidid><orcidid>https://orcid.org/0000-0002-4781-1375</orcidid><orcidid>https://orcid.org/0000-0002-1899-4942</orcidid><orcidid>https://orcid.org/0000-0003-4375-2272</orcidid><orcidid>https://orcid.org/0000-0002-3342-2651</orcidid><orcidid>https://orcid.org/0000-0003-4628-526X</orcidid><orcidid>https://orcid.org/0000-0002-8203-3791</orcidid><orcidid>https://orcid.org/0000-0002-0496-9025</orcidid><orcidid>https://orcid.org/0000-0001-9809-9536</orcidid><orcidid>https://orcid.org/0000-0003-4825-9022</orcidid><orcidid>https://orcid.org/0000-0001-7327-238X</orcidid><orcidid>https://orcid.org/0000-0003-0465-3351</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-5793
ispartof FEBS letters, 2018-06, Vol.592 (11), p.1777-1788
issn 0014-5793
1873-3468
language eng
recordid cdi_proquest_miscellaneous_2041631065
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library; Wiley Online Library (Open Access Collection); Alma/SFX Local Collection
subjects amyloid
Amyloid beta-Peptides - chemistry
beta‐breaker
Crystallography, X-Ray
HIV Envelope Protein gp120 - chemistry
HIV-1 - chemistry
Humans
peptide self‐assembly
Protein Structure, Secondary
title A novel amyloid designable scaffold and potential inhibitor inspired by GAIIG of amyloid beta and the HIV‐1 V3 loop
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T03%3A41%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20novel%20amyloid%20designable%20scaffold%20and%20potential%20inhibitor%20inspired%20by%20GAIIG%20of%20amyloid%20beta%20and%20the%20HIV%E2%80%901%20V3%20loop&rft.jtitle=FEBS%20letters&rft.au=Kokotidou,%20Chrysoula&rft.date=2018-06&rft.volume=592&rft.issue=11&rft.spage=1777&rft.epage=1788&rft.pages=1777-1788&rft.issn=0014-5793&rft.eissn=1873-3468&rft_id=info:doi/10.1002/1873-3468.13096&rft_dat=%3Cproquest_cross%3E2041631065%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2041631065&rft_id=info:pmid/29772603&rfr_iscdi=true